Skip to main content
Top
Published in: BMC Anesthesiology 1/2021

Open Access 01-12-2021 | Pleural Effusion | Research Article

Lung ultrasound predicts clinical course but not outcome in COVID-19 ICU patients: a retrospective single-center analysis

Authors: Stephanie-Susanne Stecher, Sofia Anton, Alessia Fraccaroli, Jeremias Götschke, Hans Joachim Stemmler, Michaela Barnikel

Published in: BMC Anesthesiology | Issue 1/2021

Login to get access

Abstract

Background

Point-of-care lung ultrasound (LU) is an established tool in the first assessment of patients with coronavirus disease (COVID-19). Purpose of this study was to evaluate the value of lung ultrasound in COVID-19 intensive care unit (ICU) patients in predicting clinical course and outcome.

Methods

We analyzed lung ultrasound score (LUS) of all COVID-19 patients admitted from March 2020 to December 2020 to the Internal Intensive Care Unit, Ludwig-Maximilians-University (LMU) of Munich. LU was performed according to a standardized protocol at ICU admission and in case of clinical deterioration with the need for intubation. A normal lung scores 0 points, the worst LUS has 24 points. Patients were stratified in a low (0–12 points) and a high (13–24 points) lung ultrasound score group.

Results

The study included 42 patients, 69% of them male. The most common comorbidities were hypertension (81%) and obesity (57%). The values of pH (7.42 ± 0.09 vs 7.35 ± 0.1; p = 0.047) and paO2 (107 [80–130] vs 80 [66–93] mmHg; p = 0.034) were significantly reduced in patients of the high LUS group. Furthermore, the duration of ventilation (12.5 [8.3–25] vs 36.5 [9.8–70] days; p = 0.029) was significantly prolonged in this group. Patchy subpleural thickening (n = 38; 90.5%) and subpleural consolidations (n = 23; 54.8%) were present in most patients. Pleural effusion was rare (n = 4; 9.5%). The median total LUS was 11.9 ± 3.9 points. In case of clinical deterioration with the need for intubation, LUS worsened significantly compared to baseline LU. Twelve patients died during the ICU stay (29%). There was no difference in survival in both LUS groups (75% vs 66.7%, p = 0.559).

Conclusions

LU can be a useful monitoring tool to predict clinical course but not outcome of COVID-19 ICU patients and can early recognize possible deteriorations.
Appendix
Available only for authorised users
Literature
14.
go back to reference Ishii M, Terai H, Kabata H, Masaki K, Chubachi S, Tateno H, et al. Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: a multicenter retrospective study. J Inf Secur. 2020;81(5):e3–5. Ishii M, Terai H, Kabata H, Masaki K, Chubachi S, Tateno H, et al. Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: a multicenter retrospective study. J Inf Secur. 2020;81(5):e3–5.
Metadata
Title
Lung ultrasound predicts clinical course but not outcome in COVID-19 ICU patients: a retrospective single-center analysis
Authors
Stephanie-Susanne Stecher
Sofia Anton
Alessia Fraccaroli
Jeremias Götschke
Hans Joachim Stemmler
Michaela Barnikel
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2021
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-021-01396-5

Other articles of this Issue 1/2021

BMC Anesthesiology 1/2021 Go to the issue